| Online: | |
| Visits: | |
| Stories: |
| Story Views | |
| Now: | |
| Last Hour: | |
| Last 24 Hours: | |
| Total: | |
Second US Ebola Patient, Treated With ZMapp Experimental Drug, Leaves For Atlanta
Tuesday, August 5, 2014 12:44
% of readers think this story is Fact. Add your two cents.
Dr. Kent Brantly, who is being treated with an experimental drug for the Ebola virus at Atlanta's Emory University Hospital, will soon be joined by the second American to have contracted the virus.
The drug ZMapp, made by Mapp Biopharmaceutical Inc., of San Diego, has been identified as a potential treatment for the disease but had never been tested on a human until now. The second patient, Nancy Writebol, who left for Atlanta from Monrovia, Liberia, on Tuesday, has started recovering from the disease after receiving two doses of the drug before leaving for the U.S., according to the Associated Press, or AP. ZMapp was developed by a long-running research program supported by the U.S. government and its military.
More @ International Business Times
Source: http://freenorthcarolina.blogspot.com/2014/08/second-us-ebola-patient-treated-with.html
